Home › Funds › INVESTOR AB › BMRN

INVESTOR AB position in BMRN

BIOMARIN PHARMACEUTICAL INC COM · Health Care

INVESTOR AB reported holding 3,700 shares of BMRN (BIOMARIN PHARMACEUTICAL INC COM) in its Q2 2026 13F filing — a position valued at US$212K, representing 0.00% of its reported portfolio and ranking #7 among its reported holdings. INVESTOR AB has disclosed BMRN holdings in 6 of the last 6 reported quarters, going back to Q1 2025.

Latest position (Q2 2026)3.70K sh
Reported value held$211.71K
Portfolio Weight0.00%
First reportedQ1 2025
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How INVESTOR AB's BMRN position evolved

INVESTOR AB first disclosed a stake in BMRN in Q1 2025 at 3,700 shares (US$262K). Across 6 filings, INVESTOR AB held the position steady without any share-count change. The most recent filing (Q2 2026) shows 3,700 shares valued at US$212K.

Quarter by quarter

QuarterSharesValueChange
Q1 2025 3.70K $261.55K New
Q2 2025 3.70K $203.39K Hold
Q3 2025 3.70K $200.39K Hold
Q4 2025 3.70K $219.89K Hold
Q1 2026 3.70K $209.01K Hold
Q2 2026 3.70K $211.71K Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BMRN and 13F data

BMRN (BIOMARIN PHARMACEUTICAL INC COM) is a Health Care company. 27 other funds we track also report a position in BMRN — the largest reported positions include PRIMECAP MANAGEMENT CO/CA/ (US$812.0M), Viking Global Investors (US$435.8M), VIKING GLOBAL INVESTORS LP (US$435.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BMRN

All BMRN fund holders →

FAQ

How long has INVESTOR AB held BMRN?

INVESTOR AB has disclosed BMRN holdings in 6 of the last 6 reported quarters, going back to Q1 2025.

What is INVESTOR AB's current position in BMRN?

As of Q2 2026, INVESTOR AB holds 3.70K shares of BMRN (BIOMARIN PHARMACEUTICAL INC COM), valued at $211.71K, representing 0.00% of its reported portfolio and ranking #7.

Has INVESTOR AB been buying or selling BMRN?

In the latest 13F filing (Q2 2026), INVESTOR AB held unchanged its position in BMRN.

Which other funds hold BMRN?

Other major institutional holders of BMRN include PRIMECAP MANAGEMENT CO/CA/, Viking Global Investors, VIKING GLOBAL INVESTORS LP, among 27 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.